LSM-775

LSM-775
Systematic (IUPAC) name
(8β)-6-Methyl-8-(morpholin-4-ylcarbonyl)-9,10-didehydroergoline
Clinical data
Routes of
administration
Oral
Pharmacokinetic data
Metabolism hepatic
Excretion renal
Identifiers
CAS Number 4314-63-0 YesY
PubChem CID 199507
ChemSpider 172695 YesY
Synonyms LSM-775, N-Morpholinyllysergamide, Lysergic acid morpholide
Chemical data
Formula C20H23N3O2
Molar mass 337.43 g/mol
  (verify)

N-Morpholinyllysergamide (LSM-775) is a derivative of ergine.[1] It is reported to have some LSD-like effects at doses ranging from 75 to 700 micrograms and a shorter duration and that there fewer signs of cardiovascular stimulation and peripheral toxicity compared to LSD-25.[2]

References

  1. John H. Gogerty, James M. Dille (July 1957). "Pharmacology of d-lysergic acid morpholide (LSM)". The Journal of Pharmacology And Experimental Therapeutics 120 (3): 340–348. PMID 13476356.
  2. Alexander and Ann Shulgin. "TiHKAL #26, LSD-25". Erowid.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.